eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Cephalon (UK) Limited

Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB
Telephone: +44 (0) 207 5407117
Fax: +44 (0) 207 4507349
WWW: http://www.tevauk.com
Medical Information Direct Line: +44 (0) 207 5407117
Medical Information e-mail: medinfo@tevauk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 22/09/2011
PIL Myocet

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Introduction of new pack/pack size
Updated on 21/04/2011 and displayed until 22/09/2011
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 26/08/2010 and displayed until 21/04/2011
Reasons for adding or updating:
  • Change of active ingredient
  • Change of inactive ingredient
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
Updated on 15/04/2010 and displayed until 26/08/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 06/05/2009 and displayed until 15/04/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 03/06/2008 and displayed until 06/05/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 24/10/2007 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 01/08/2006 and displayed until 24/10/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/08/2001 and displayed until 01/08/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   doxorubicin hydrochloride